Highest-materiality recent filing
Avery Dennison Q2 2026: adj. EPS $2.89, up 19.4%; sales $2.5B, up 10.9%
Reported EPS $2.67; adjusted EPS $2.89, up 19.4% YoY.
Avery Dennison Q1 adj EPS $2.47, up 7.4%; guides Q2 adj EPS $2.43-$2.53
Reported EPS $2.18; adjusted EPS $2.47 (+7.4% YoY). Net sales $2.3B, +7.0%.
Avery Dennison reports FY25 adj EPS $9.53 (+1%), Q4 adj EPS $2.45 (+3%), sales $8.9B
FY25 reported EPS $8.79; adjusted EPS $9.53, up 1% YoY.
Avery Dennison Q3 adjusted EPS $2.37 (+2%), net sales $2.2B (+1.5%)
Reported EPS $2.13; adjusted EPS $2.37, up 2% YoY.
Avery Dennison Q2 2025 adj. EPS $2.42, flat YoY; Q3 guidance adj. EPS $2.24-$2.40
Reported EPS $2.41; adjusted EPS $2.42, flat versus prior year, up 5% sequentially.
Board authorized up to $750M in additional share repurchases (excluding fees).
Reported EPS $2.09; adjusted EPS $2.30 (up 0.4% YoY, ~4% ex currency).
Avery Dennison Q4 adj EPS $2.38, FY adj EPS $9.43 (up 19%); guides FY25 adj EPS $9.80-10.20
Q4 2024 net sales $2.2B (+3.6%); reported EPS $2.16, adjusted EPS $2.38 (+10%).
Avery Dennison CFO Gregory Lovins takes medical leave; Danny Allouche named Interim CFO
CFO Gregory Lovins began medical leave Nov 14, 2024; ceased as principal financial officer.
3Q24 reported EPS $2.25 (+32% YoY); adjusted EPS $2.33 (+9% YoY).
Avery Dennison Q2 adjusted EPS $2.42 (+26%); raises FY adjusted EPS guidance to $9.30-9.50
Reported EPS $2.18 (+76%), adjusted EPS $2.42 (+26%) on net sales $2.2B (+7% organic).
Avery Dennison appoints former WestRock CFO Ward Dickson to board, as Audit Chair
Ward Dickson appointed to Board effective June 1, 2024; named Chair of Audit Committee and member of Finance Committee.
Avery Dennison Q1 EPS $2.13 (+43% YoY); adj. EPS $2.29 (+35%); raises FY guidance
Reported EPS $2.13, up 43% YoY; adjusted EPS $2.29, up 35% YoY.
Avery Dennison Q4 adj. EPS $2.16 (+31%); FY24 guidance $9.00-$9.50
4Q23 reported EPS $1.77, adjusted EPS $2.16 (up 31% YoY); net sales $2.1B, up 4%.
Avery Dennison Q3 net sales $2.1B, down 11% organic; adjusted EPS $2.10, up 9% sequentially
Q3 reported EPS $1.71; adjusted EPS $2.10 (non-GAAP), up 9% from Q2 2023.
Net sales $2.1B, organic sales change -10% (non-GAAP); sales change ex-currency also -10%.
Avery Dennison loses patent retrial vs ADASA; liability range may exceed $71M
Jury on July 18, 2023, found ADASA's patent valid, rejecting Avery's anticipation/obviousness defenses.
Avery Dennison announces CEO succession: Deon Stander to become CEO, Mitch Butier Executive Chairman
Deon Stander, age 54, elected President and CEO effective September 1, 2023; succeeds Mitch Butier.
Avery Dennison Q1 adjusted EPS $1.70 (-29% YoY); sales down 12%; FY guidance cut
Q1 reported EPS $1.49; adjusted EPS $1.70, down 29% year-over-year.
Avery Dennison prices $400M of 5.75% Senior Notes due 2033; proceeds to refinance debt
$400M aggregate principal of 5.750% Senior Notes due 2033; closing expected March 15, 2023.
Avery Dennison FY22 adjusted EPS $9.15 (+3%); Q4 adj. EPS $1.65 (-23%); FY23 guidance $9.15-$9.55
FY22 reported EPS $9.21, adj. EPS $9.15 up 3%; net sales $9.0B up 7.5% (ex-currency +13.1%).
Avery Dennison Q3 EPS $2.70 (+38% YoY); net sales up 11.8% to $2.3B; narrows FY22 guidance
Reported EPS $2.70 (up 38% YoY); adjusted EPS $2.46 (up 15% YoY).
Avery Dennison Q2 EPS $2.61; raises FY22 adjusted EPS guidance to $9.70-$10.00
Reported EPS $2.61; adjusted EPS (non-GAAP) $2.64.
Avery Dennison Board Authorizes $750M Share Repurchase
Board authorized additional share repurchases of up to $750M, effective April 28, 2022, supplementing prior buyback programs.
On October 9, 2026, the Board of Directors (the “Board”) of Avery Dennison Corporation, a Delaware corporation (the “Company”), elected Helen J. Sheirbon as President, Solutions Group, and an “executive officer” of the Company under the rules of the Securities and Exchange Commission, effective November 3, 2026.
On May 31, 2026, the Company’s Board of Directors (the “Board”) elected Danny G. Allouche as the Company’s President, Materials Group, effective June 1, 2026.
On May 29, 2026, Ryan D. Yost, President, Materials Group, of Avery Dennison Corporation, a Delaware corporation (the "Company"), notified the Company of his decision to resign to accept another opportunity.
Danny G. Allouche will cease serving as the Company’s Interim Chief Financial Officer and principal financial officer on March 31, 2025; he will continue serving as the Company’s Senior Vice President and Chief Strategy and Corporate Development Officer.
Effective April 1, 2025, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the “Company”), will resume serving as the Company’s principal financial officer following a previously disclosed medical leave of absence that began on November 14, 2024.
On December 27, 2024, Martha N. Sullivan, a 12-year member of the Board of Directors (the “Board”) of Avery Dennison Corporation, a Delaware corporation (the “Company”), notified the Company’s Executive Chairman, its Chief Executive Officer, the Board’s Lead Independent Director and the Board’s Governance Committee Chair of her decision to resign from the Board effective December 31, 2024 to pursue new professional opportunities.
On November 14, 2024, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the "Company"), began a medical leave of absence.
On November 14, 2024, the Company’s Board of Directors (the “Board”) elected Danny G. Allouche as the Company’s Senior Vice President and Interim Chief Financial Officer, effective November 15, 2024.
appointed Ward Dickson as a director, effective June 1, 2024.
On February 20, 2024, Julia A. Stewart, a 21-year member of the Board of Directors ('Board') of Avery Dennison Corporation (the 'Company'), notified the Company’s Executive Chairman and Lead Independent Director of her decision not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on April 25, 2024 (the 'Annual Meeting') in order to dedicate her efforts to the health and wellness venture she founded.
On February 22, 2024, upon the recommendation of its Governance Committee, the Board appointed Maria Fernanda Mejia as a director, effective on that date.
On November 20, 2023, Anthony K. Anderson notified the Executive Chairman of the Board of Directors (the “Board”) of Avery Dennison Corporation of his decision to resign from the Board effective November 30, 2023.
Max materiality 0.80 · Median 0.55 · Most common event leadership